Key Points:
Results of a poll posted on the Interventional Section of ACC.org over the last two weeks assessed planned management strategies of patients with diagnosed or presumed COVID – 19 presenting with STEMI or NSTEMI during the Coronavirus Pandemic. The results from over 1800 participants demonstrate:
For STEMI presentations – Treatment choices were thrombolytics (44%) over traditional primary PCI (33%) while 23% thought decisions should be hospital-based.
For NSTEMI presentations – the predominant treatment choice was medical treatment in the absence of Shock (63%), usual card with risk assessment and appropriate early angiography (21%), while 16% thought decision protocols should be hospital-based.